Comparison of the Analgesic Effect of Subsartorial Saphenous Block and Popliteal Sciatic vs Subsartorial Saphenous Block and IPACK in Total Knee Replacement Surgery. A Double Blind Randomized Clinical Trial.

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Total knee replacement surgery is associated with significant pain in the immediate postoperative period, especially in movement. In turn, this is associated with more subsequent chronic pain. There are multiple options and the tendency is to perform increasingly distal nerve blocks to minimize limb weakness and thus allow early rehabilitation. In 2012, in an oral communication, Sanjay Sinha described a new nerve block called iPACK (Interspace between the Popliteal Artery and the Capsule of the posterior Knee). There are few studies on the efficacy of such a blockade so far, but none comparing the groups saphene + sciatic blocks vs. saphene + iPACK blocks. Therefore, this study aims to provide more information on the effectiveness this nerve blocks, in total knee replacement, in terms of analgesia and motor function.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with osteoarthritis scheduled for total primary knee arthroplasty with same surgeons

• Locoregional anesthesia

• Age equal to or greater than 18 years

• Consent to participate in the study

Locations
Other Locations
Spain
Hospital Universitari Germans Trias i Pujol
RECRUITING
Badalona
Contact Information
Primary
Madalina Dinu, Mrs
madidinu@hotmail.com
0034600349517
Time Frame
Start Date: 2020-06-10
Estimated Completion Date: 2024-08-01
Participants
Target number of participants: 62
Treatments
Experimental: Echo-guided IPACK block
IPACK block using 0.25% bupivacaine 15mL with adrenaline once.
Active_comparator: Echo-guided sciatic block
Sciatic nerve block using 0.25% bupivacaine 15mL with adrenaline once.
Sponsors
Leads: Germans Trias i Pujol Hospital

This content was sourced from clinicaltrials.gov